Jeremy Bender's most recent trade in Day One Biopharmaceuticals Inc was a trade of 13,964 Common Stock done at an average price of $6.3 . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 15 May 2025 | 13,964 | 145,737 | - | 6.3 | 87,385 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 11,687 | 159,701 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 11,687 | 148,014 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 11,687 | 163,626 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 11,687 | 116,878 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 4,750 | 136,327 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 4,750 | 28,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 3,562 | 131,577 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 3,562 | 7,132 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 11.96 per share. | 15 Feb 2025 | 12,048 | 128,015 | - | 12.0 | 144,130 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 128,376 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 140,063 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 128,565 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 175,313 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,750 | 116,689 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,750 | 33,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,562 | 111,939 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,562 | 10,694 | - | - | Restricted Stock Unit (RSU) | |
| Mereo Biopharma Group Plc ... | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 55,000 | 55,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Group Plc ... | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 16,768 | 16,768 | - | - | Deferred Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 286,000 | 286,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 187,000 | 187,000 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 11,687 | 118,931 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 11,687 | 140,252 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 13.21 per share. | 15 Nov 2024 | 10,554 | 108,377 | - | 13.2 | 139,420 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 4,750 | 107,244 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 4,750 | 38,000 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 3,562 | 102,494 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 3,562 | 14,256 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 11,687 | 109,613 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 11,687 | 151,939 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Aug 2024 | 10,681 | 98,932 | - | 14.0 | 149,524 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 4,750 | 97,926 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 4,750 | 42,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,562 | 93,176 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,562 | 17,818 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 80,619 | 219,406 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 80,619 | 734,414 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 72,612 | 197,614 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 72,612 | 807,026 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 59,075 | 162,762 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 59,075 | 624,189 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 29,606 | 653,795 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 29,606 | 222,030 | - | 0 | Common Stock | |
| Mereo Biopharma Group Plc ... | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 3.99 per share. | 17 Jun 2024 | 12,550 | 12,550 | - | 4.0 | 50,075 | American Depositary Shares representing Ordinary Shares |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 11,687 | 662,601 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 11,687 | 163,626 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 15 May 2024 | 7,873 | 654,728 | - | 16.1 | 126,588 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 4,750 | 650,914 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 4,750 | 47,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,562 | 21,380 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,562 | 646,164 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 17.88 per share. | 01 May 2024 | 70,051 | 651,762 | - | 17.9 | 1,252,183 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 17.85 per share. | 01 May 2024 | 9,154 | 642,602 | - | 17.9 | 163,417 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 01 May 2024 | 6 | 651,756 | - | 18 | 108 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 11,687 | 729,428 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Bender Jeremy | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 11,687 | 175,313 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 15 Feb 2024 | 7,615 | 721,813 | - | 15.2 | 116,114 | Common Stock |
| Day One Biopharmaceuticals... | Bender Jeremy | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,750 | 52,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,750 | 717,741 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 3,562 | 712,991 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Bender Jeremy | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 3,562 | 24,942 | - | - | Restricted Stock Unit (RSU) | |
| Mereo Biopharma Group Plc ... | Bender Jeremy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Group Plc ... | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 16,361 | 16,361 | - | - | Deferred Restricted Stock Units | |
| Day One Biopharmaceuticals... | Bender Jeremy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 286,000 | 286,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 187,000 | 187,000 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 4,750 | 707,220 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 4,750 | 61,750 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 3,562 | 702,470 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 3,562 | 32,066 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.86 per share. | 15 Aug 2023 | 2,996 | 704,224 | - | 13.9 | 41,525 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 240,288 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 0 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 240,288 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 698,908 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 240,288 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 939,196 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 59,737 | 300,025 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 59,737 | 221,837 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 29,938 | 270,226 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 29,938 | 251,636 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 4,750 | 66,500 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 4,750 | 1,182,588 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 3,562 | 35,628 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 3,562 | 1,177,838 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.12 per share. | 15 May 2023 | 3,104 | 1,179,484 | - | 13.1 | 40,732 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 07 Mar 2023 | 12,500 | 1,174,276 | - | 20.0 | 250,114 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 4,750 | 71,250 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 4,750 | 1,189,798 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 3,562 | 1,185,048 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 3,562 | 39,190 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.57 per share. | 15 Feb 2023 | 3,022 | 1,186,776 | - | 19.6 | 59,150 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 23 Jan 2023 | 12,500 | 1,181,486 | - | 22.0 | 274,988 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 244,000 | 244,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 76,000 | 76,000 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 281,574 | 1,192,424 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 281,574 | 281,574 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 281,574 | 1,192,424 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 281,574 | 281,574 | - | 0 | Common Stock | |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.32 per share. | 21 Dec 2022 | 12,500 | 1,192,424 | - | 20.3 | 253,969 | Common Stock |
| Day One Biopharmaceuticals... | Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.74 per share. | 21 Nov 2022 | 12,100 | 1,205,324 | - | 20.7 | 250,927 | Common Stock |